Diabetes and travel — managing meals across time zones

Diabetes travel across time zones disrupts every element of glucose management simultaneously: meal timing shifts, insulin action curves misalign with eating patterns, airport food options are unpredictable, and the stress of travel independently raises cortisol and blood glucose. A flight from New York to London shifts the day by 5 hours east; if you were injecting basal insulin at 10 PM New York time, your “10 PM dose” now needs to happen at 3 AM London time — or you need a dose adjustment protocol for the transition. Flying west (gaining hours) extends the day, requiring additional coverage; flying east (losing hours) shortens the day, requiring dose reduction. Per the ADA and Joslin Diabetes Center travel protocols, people with Type 1 diabetes should aim to maintain glucose between 140–180 mg/dL during long-haul flights — a slightly higher target than usual to create a safety buffer against airport-delayed meals and unpredictable inflight carbohydrate content. Getting a travel letter from your endocrinologist, carrying duplicate supplies, and understanding the insulin stability window in ambient temperature are the preparation fundamentals. The meal management layer — what to eat in airports, on planes, and during the first 72 hours of circadian disruption — is what most travel diabetes guides omit.

Eastbound vs westbound travel — the insulin adjustment rules

Crossing time zones requires a systematic approach to basal insulin adjustment that most patients never receive as explicit protocol from their care teams. The rules differ meaningfully by direction of travel.

Westbound travel (gaining hours, longer day): when you fly west across multiple time zones, your day lengthens. A flight from London to Los Angeles gains 8 hours, stretching a 24-hour day into a 32-hour day from the insulin’s perspective. If you take long-acting basal insulin once daily, that 8-hour extension is an 8-hour gap in coverage. The clinical recommendation is to take approximately one-third of your usual daily basal dose at the destination bedtime in addition to your home-time dose — effectively splitting the coverage across the extended day.¹ The exact proportion depends on hours gained: a 3-hour westbound shift (New York to Los Angeles) typically requires only a small correction dose, whereas an 8–10 hour shift across the Pacific warrants a more substantial split-dose approach.

Eastbound travel (losing hours, shorter day): flying east compresses the day. London to Delhi is a 4.5-hour gain; New York to London is a 5-hour gain. A compressed day means your basal insulin dose covers more hours than the shortened day requires, increasing hypoglycemia risk. The standard protocol for eastbound travel is to reduce the basal dose on the travel day by the proportion of hours lost — roughly 10–15% per 3 hours of time gained. For a 6-hour eastbound jump, a 20–25% basal reduction on travel day is a reasonable starting calculation.¹

Worked example: New York to London (5 hours east, 19-hour travel day). A patient taking 20 units of glargine at 10 PM New York time would normally take their next dose at 10 PM London time — which is 5 AM New York time, 19 hours after the previous dose rather than 24. Options: reduce the next dose by approximately 20–25% (to 15–16 units) and resume full dosing the following night; or delay the London-time injection slightly toward midnight to spread the gap more evenly. Both approaches are defensible; the endocrinologist should specify which prior to travel.

Pump users: insulin pumps are time-zone agnostic in terms of the actual insulin delivery, but the programmed basal rates are clock-driven. Updating the pump clock to destination time immediately on arrival is the recommended approach, after which the existing basal profile delivers at the new local times. This assumes your basal rates are well-optimised; a poorly tuned basal profile that relies on a specific bolus pattern to compensate will need adjustment separately.²

Target glucose during transit: 140–180 mg/dL is the Joslin Diabetes Center recommendation, allowing a hypoglycemia buffer during a period when access to glucose treatment may be limited and monitoring may be less frequent than usual.

Airport eating — carb counts for common terminal food options

Airport food is consistently one of the highest-risk environments for inaccurate carb counting. Chain outlets often publish nutrition data online, but the gap between listed and actual carbohydrate content at busy terminals is real. A 2011 study in JAMA found that restaurant-prepared meals deviated from stated calorie counts by more than 100 kcal in 19% of cases, with some outliers at 400–500 kcal.³ Carbohydrate divergence follows a similar pattern.

Reference carb counts for 15 common airport items:

Pret A Manger tuna baguette: approximately 60–65 g carbohydrate. Starbucks blueberry muffin: 58 g. McDonald’s regular hash brown: 15 g (low risk). McDonald’s medium fries: 44 g. Airport coffee-chain pastry (croissant): 26 g. Airport bagel with cream cheese: 52 g. Smoothie bowl (medium, açaí base): 65–75 g. Terminal sandwich (wheat bread, standard filling): 40–50 g. Granola bar (standard 40 g): 27 g. Greek yogurt pot (150 g, flavoured): 18–22 g. Protein bar (typical low-carb brand): 8–20 g depending on sugar alcohol content. Banana (medium): 27 g. Orange juice (330 ml): 36 g. Cheese and cracker pack: 15–20 g. Mixed nuts (28 g): 6 g.⁴

Lowest-risk ordering strategies when carb content is unknown: choose items with a single dominant protein (grilled chicken, hard-boiled eggs, cheese), avoid sauced or glazed items where carbohydrate is invisible, skip fruit-forward smoothies, and when uncertain, err toward a slightly conservative bolus with a 1-hour post-meal check planned. See our guide to calorie counting at restaurants for a fuller breakdown of how to estimate portions when menus lack nutrition data. Many airports now have pharmacies selling glucose gel or tablets — note the location before you need it.

Inflight meal management — timing, content, and insulin on a plane

Inflight meal timing is one of the most common causes of post-meal hypoglycemia in people with Type 1 diabetes on long-haul flights. The standard recommendation from Joslin and the UK TREND diabetes travel guide is to inject after the meal tray arrives and you can see the actual carbohydrate content — not before.¹ This inverts the usual pre-meal bolus timing of 10–15 minutes, but it is the correct approach when the meal delivery window is genuinely uncertain.

Why the timing matters: rapid-acting insulin analogues (aspart, lispro, glulisine) typically peak 45–90 minutes post-injection. If you inject at an estimated meal time and the trolley arrives 45 minutes late — not uncommon on long-haul services — your insulin is already peaking as you begin eating, and the post-meal glucose excursion will be blunted, followed by a late trough as both the food glucose and the residual insulin action converge.

Typical long-haul meal carbohydrate contents: economy class meals vary substantially by airline, but a common structure is: a bread roll (25–30 g), a main dish with rice or pasta (30–50 g carbohydrate in the starch component), a dessert (25–40 g), and a side salad or fruit (5–15 g). Total: approximately 85–135 g carbohydrate for a full economy tray. Business class meals tend toward lower carbohydrate density with more protein, but this varies widely. Requesting a diabetic meal through the airline (usually a low-sugar, lower-carbohydrate option) provides a slightly more predictable content, though the carb count is still not guaranteed.⁴

Altitude effects on insulin absorption: cabin pressure on commercial flights is maintained at an equivalent of approximately 6,000–8,000 feet, not sea level. Some evidence suggests marginally faster insulin absorption at altitude due to mild vasodilation, though the clinical magnitude of this effect is small in most patients and not sufficient to change dosing protocol.⁵ The more practical concern is that subcutaneous insulin absorption can be altered by the cold, dehydration, and reduced physical activity during a long flight — factors that collectively tend to slow absorption slightly and increase post-flight hyperglycemia risk.

Alcohol on the plane: alcohol inhibits hepatic glucose production and increases hypoglycemia risk for up to 12–16 hours after ingestion in people on insulin. One or two drinks during a long flight is not prohibited, but the glycemic effect is additive with any overnight basal insulin on board. Checking glucose before sleeping and setting a CGM low alert at 80–90 mg/dL is sensible.²

Managing glucose during severe circadian disruption — the first 72 hours

The first three days after a long-haul crossing are the most unpredictable period for glucose management. Three independent mechanisms operate simultaneously: cortisol rhythm disruption, sleep deprivation-driven insulin resistance, and meal timing misalignment with your internal clock.

Cortisol and glucose: cortisol is the primary counter-regulatory hormone that produces the dawn phenomenon, and it follows a circadian pattern anchored to local light exposure. After a 10-hour eastbound crossing, your cortisol peak — normally at 6–8 AM — arrives at a dislocated time relative to the destination clock. This can produce unexpected early-morning hyperglycemia on days 1–3 that does not correspond to dawn phenomenon in the usual sense — it is an artefact of cortisol rhythm displacement.⁵ Checking glucose at 2–3 AM and 6 AM on the first three mornings after arrival provides the data needed to identify whether this is occurring and in which direction.

Sleep deprivation and insulin resistance: a single night of poor sleep increases insulin resistance measurably. A study in Diabetes Care found that even one night of restricted sleep (4 hours) reduced insulin sensitivity by approximately 20% in healthy adults — an effect likely larger in people with pre-existing insulin resistance.⁵ During the adaptation period, blood glucose may run higher than expected from a given carbohydrate intake, requiring modest upward ICR adjustments.

The 72-hour protocol: maintain consistent meal timing on the destination clock from day 1 rather than eating whenever you feel hungry (which will be at your home-time meal patterns). Limit large restaurant meals on days 1–2 where carbohydrate content is uncertain. Check glucose every 2–3 hours during waking on days 1–2. Avoid the reflex of continuous eating to stay awake — it produces sustained post-meal hyperglycemia that compounds jet lag recovery. Prioritise sleep over social eating in the first 48 hours after arrival.

Insulin storage during travel — heat, altitude, and TSA logistics

Insulin stability depends on temperature and should be actively managed throughout the travel period.

Temperature limits: insulin in use (opened vials or cartridges) is stable at room temperature (up to 25–30°C depending on type) for approximately 28–30 days. Unopened insulin should be refrigerated at 2–8°C but not frozen. Cargo holds in aircraft can reach temperatures below freezing at altitude — frozen insulin loses potency and should not be used.¹ All insulin must travel in carry-on luggage, not checked bags.

Tropical destinations: ambient temperatures above 30°C for prolonged periods degrade insulin faster. A Frio evaporative cooling wallet (activated with water and air-dried) maintains insulin within the safe range for 45 hours of ambient heat up to 37°C. For longer hot-weather travel, reactivating the Frio wallet every 48 hours is sufficient.

TSA and international security: insulin, syringes, pens, pump supplies, glucose meters, CGM sensors and transmitters, and lancing devices are all permitted through security in carry-on baggage. TSA’s medical exception applies without requiring a prescription label, though having one prevents delays. An endocrinologist letter on clinic letterhead stating the patient’s diagnosis, insulin type, and the requirement to carry supplies is useful for international destinations with stricter carry-on policies — particularly some Middle Eastern and South Asian airports that apply additional screening to injectable medications.¹

Building a diabetes travel kit — the 14-item checklist

A comprehensive diabetes travel kit must account for supply failures that become serious problems far from home:

1. Insulin — twice the expected quantity for the trip, stored in two separate bags across two items of carry-on
2. Syringes or pen needles — 1.5× expected supply plus spares of each gauge used
3. Blood glucose meter — two meters (battery failure and loss both occur)
4. Test strips — 1.5× expected supply
5. CGM sensors — at least one spare per week of travel
6. CGM transmitter and receiver or phone backup
7. Lancets — 1.5× supply
8. Fast-acting glucose — glucose tablets (preferred for dosing precision), glucose gel, or sealed juice boxes; at least 60–80 g fast glucose
9. Glucagon kit (nasal or injection) — one per trip minimum
10. Insulin pump supplies (if applicable): reservoirs, infusion sets, adhesive, insulin tubes — 1.5× supply
11. Endocrinologist letter — on clinic letterhead, signed, listing diagnosis, all medications, and needle/syringe requirement
12. Prescription labels on all medications (for customs clearance)
13. List of local emergency contacts and diabetes clinics at destination — check the International Diabetes Federation directory
14. Travel health insurance documentation with explicit coverage confirmation for diabetes-related emergencies¹

Pre-travel: refill all prescriptions 2 weeks before departure. Bring a list of insulin brand equivalents available at the destination — not all countries stock every insulin formulation, and knowing the local equivalent of your usual product could matter in an emergency.

References

1. Joslin Diabetes Center Clinical Guidelines. “Traveling with Diabetes.” Joslin Diabetes Center, Boston. Updated 2023. Available at joslin.org/patient-care/diabetes-education/diabetes-travel.

2. American Diabetes Association Professional Practice Committee. “Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2024.” Diabetes Care 47, Supplement 1 (2024): S77–S110.

3. Urban LE, McCrory MA, Dallal GE, et al. “Accuracy of Stated Energy Contents of Restaurant Foods.” JAMA 306, no. 3 (2011): 287–293.

4. Collazo-Clavell ML, Guthrie RA, Lauber AC. “Travel and Diabetes.” Clinical Diabetes 21, no. 2 (2003): 82–87.

5. Donga E, van Dijk M, van Dijk JG, et al. “A Single Night of Partial Sleep Deprivation Induces Insulin Resistance in Multiple Metabolic Pathways in Healthy Subjects.” Journal of Clinical Endocrinology & Metabolism 95, no. 6 (2010): 2963–2968.

6. Iqbal N. “The Air Travel Patient with Diabetes Mellitus.” Travel Medicine and Infectious Disease 5, no. 5 (2007): 275–283.